BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22698401)

  • 1. LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.
    Liu W; Monahan KB; Pfefferle AD; Shimamura T; Sorrentino J; Chan KT; Roadcap DW; Ollila DW; Thomas NE; Castrillon DH; Miller CR; Perou CM; Wong KK; Bear JE; Sharpless NE
    Cancer Cell; 2012 Jun; 21(6):751-64. PubMed ID: 22698401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients.
    Boudeau J; Kieloch A; Alessi DR; Stella A; Guanti G; Resta N
    Hum Mutat; 2003 Feb; 21(2):172. PubMed ID: 12552571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LKB1 modulates lung cancer differentiation and metastasis.
    Ji H; Ramsey MR; Hayes DN; Fan C; McNamara K; Kozlowski P; Torrice C; Wu MC; Shimamura T; Perera SA; Liang MC; Cai D; Naumov GN; Bao L; Contreras CM; Li D; Chen L; Krishnamurthy J; Koivunen J; Chirieac LR; Padera RF; Bronson RT; Lindeman NI; Christiani DC; Lin X; Shapiro GI; Jänne PA; Johnson BE; Meyerson M; Kwiatkowski DJ; Castrillon DH; Bardeesy N; Sharpless NE; Wong KK
    Nature; 2007 Aug; 448(7155):807-10. PubMed ID: 17676035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas.
    Rowan A; Bataille V; MacKie R; Healy E; Bicknell D; Bodmer W; Tomlinson I
    J Invest Dermatol; 1999 Apr; 112(4):509-11. PubMed ID: 10201537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinoma.
    Osoegawa A; Kometani T; Nosaki K; Ondo K; Hamatake M; Hirai F; Seto T; Sugio K; Ichinose Y
    Jpn J Clin Oncol; 2011 Sep; 41(9):1132-7. PubMed ID: 21816872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors.
    Carretero J; Shimamura T; Rikova K; Jackson AL; Wilkerson MD; Borgman CL; Buttarazzi MS; Sanofsky BA; McNamara KL; Brandstetter KA; Walton ZE; Gu TL; Silva JC; Crosby K; Shapiro GI; Maira SM; Ji H; Castrillon DH; Kim CF; García-Echeverría C; Bardeesy N; Sharpless NE; Hayes ND; Kim WY; Engelman JA; Wong KK
    Cancer Cell; 2010 Jun; 17(6):547-59. PubMed ID: 20541700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.
    Su GH; Hruban RH; Bansal RK; Bova GS; Tang DJ; Shekher MC; Westerman AM; Entius MM; Goggins M; Yeo CJ; Kern SE
    Am J Pathol; 1999 Jun; 154(6):1835-40. PubMed ID: 10362809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.
    Lin-Marq N; Borel C; Antonarakis SE
    Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.
    Guldberg P; thor Straten P; Ahrenkiel V; Seremet T; Kirkin AF; Zeuthen J
    Oncogene; 1999 Mar; 18(9):1777-80. PubMed ID: 10208439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer.
    Baker AM; Cox TR; Bird D; Lang G; Murray GI; Sun XF; Southall SM; Wilson JR; Erler JT
    J Natl Cancer Inst; 2011 Mar; 103(5):407-24. PubMed ID: 21282564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXC11-SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib.
    deBlacam C; Byrne C; Hughes E; McIlroy M; Bane F; Hill AD; Young LS
    Br J Cancer; 2011 Jun; 105(1):118-23. PubMed ID: 21654685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome.
    Connolly DC; Katabuchi H; Cliby WA; Cho KR
    Am J Pathol; 2000 Jan; 156(1):339-45. PubMed ID: 10623683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
    Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
    Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation.
    Granado-Martínez P; Garcia-Ortega S; González-Sánchez E; McGrail K; Selgas R; Grueso J; Gil R; Naldaiz-Gastesi N; Rhodes AC; Hernandez-Losa J; Ferrer B; Canals F; Villanueva J; Méndez O; Espinosa-Gil S; Lizcano JM; Muñoz-Couselo E; García-Patos V; Recio JA
    Commun Biol; 2020 Jul; 3(1):366. PubMed ID: 32647375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome.
    Entius MM; Keller JJ; Westerman AM; van Rees BP; van Velthuysen ML; de Goeij AF; Wilson JH; Giardiello FM; Offerhaus GJ
    J Clin Pathol; 2001 Feb; 54(2):126-31. PubMed ID: 11215281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.
    Nogueira C; Kim KH; Sung H; Paraiso KH; Dannenberg JH; Bosenberg M; Chin L; Kim M
    Oncogene; 2010 Nov; 29(47):6222-32. PubMed ID: 20711233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis.
    Burgos-Ojeda D; Wu R; McLean K; Chen YC; Talpaz M; Yoon E; Cho KR; Buckanovich RJ
    Mol Cancer Ther; 2015 Jul; 14(7):1717-27. PubMed ID: 25969154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
    Zeng PY; Berger SL
    Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
    Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
    Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F1-dependent oncogenic addiction of melanoma cells to MDM2.
    Verhaegen M; Checinska A; Riblett MB; Wang S; Soengas MS
    Oncogene; 2012 Feb; 31(7):828-41. PubMed ID: 21743494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.